News

Novo Nordisk launches weight-loss drug Wegovy in India to compete with Lilly's Mounjaro
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...
Novo Nordisk split puts Hims & Hers future in question
Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...
Wegovy, Novo Nordisk's weight loss drug launched in India, check pricing and dosage
Wegovy is a GLP-1 receptor agonist that acts on key areas of the brain involved in appetite regulation and food intake ...
Novo Nordisk’s New Obesity Drug Beats Wegovy Weight Loss in Early Trial
Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.
Novo Nordisk launches weight loss drug Wegovy priced at ₹17,345 per month
Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...
Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly's Mounjaro
By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss ...
Finbold2d
Hims & Hers stock crashes over 20% on Wegovy shocker
Hims & Hers Health stock plunged after Novo Nordisk (NYSE: NVO) cut ties over concerns about its handling of Wegovy ...
24/7 Wall St.5d
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...